Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Mersana Therapeutics, Inc. | tm2019073d8_ex5-1.htm |
| EX-1.1 - EXHIBIT 1.1 - Mersana Therapeutics, Inc. | tm2019073d8_ex1-01.htm |
| 8-K - FORM 8-K - Mersana Therapeutics, Inc. | tm2019073-8_8k.htm |
Exhibit 99.1
Information Relating to Part II.
Item 14. — Other Expenses of Issuance and Distribution
The expenses in connection with the offer and sale of shares of common stock of Mersana Therapeutics, Inc. registered pursuant to the Registration Statement on Form S-3 (Registration No. 333-238140) filed on May 8, 2020, other than underwriting discounts and commissions, are set forth in the following table. All amounts are estimated.
| Printing and engraving expenses | $ | 25,000 | ||
| Legal fees and expenses | $ | 175,000 | ||
| Accounting fees and expenses | $ | 75,000 | ||
| Transfer Agent and Registrar fees | $ | 10,000 | ||
| Miscellaneous | $ | 15,000 | ||
| Total | $ | 300,000 |